Equities

Nippon Chemiphar Co Ltd

4539:TYO

Nippon Chemiphar Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)1,583.00
  • Today's Change1.00 / 0.06%
  • Shares traded900.00
  • 1 Year change-16.24%
  • Beta0.7225
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments9,20010,52911,645
Total Receivables, Net11,54611,47412,644
Total Inventory10,72210,7558,811
Prepaid expenses------
Other current assets, total368678395
Total current assets31,83633,43633,495
Property, plant & equipment, net13,22411,51811,848
Goodwill, net------
Intangibles, net281569884
Long term investments2,0661,3851,810
Note receivable - long term------
Other long term assets415413419
Total assets49,54848,57149,453
LIABILITIES
Accounts payable6,9788,9449,566
Accrued expenses2,3331,7692,150
Notes payable/short-term debt568392400
Current portion long-term debt/capital leases2,8872,7272,854
Other current liabilities, total1,0209341,780
Total current liabilities13,78614,76616,750
Total long term debt13,52612,11111,534
Total debt16,98115,23014,788
Deferred income tax915915915
Minority interest------
Other liabilities, total2,8612,2451,753
Total liabilities31,08830,03730,952
SHAREHOLDERS EQUITY
Common stock4,3044,3044,304
Additional paid-in capital1,2631,2631,263
Retained earnings (accumulated deficit)13,27313,65313,499
Treasury stock - common(3111)(3110)(3110)
Unrealized gain (loss)2,5272,4072,617
Other equity, total20417(72)
Total equity18,46018,53418,501
Total liabilities & shareholders' equity49,54848,57149,453
Total common shares outstanding3.613.613.61
Treasury shares - common primary issue0.650.650.65
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.